Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus

Arthur E. Frankel, Wai C. Yip, Eknath Naik, Hans C. Hasselbalch

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A 61-year-old male on everolimus had chronic SARS-CoV-2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with everolimus plus interferon for COVID-19.

Original languageEnglish (US)
Article numbere04218
JournalClinical Case Reports
Volume9
Issue number6
DOIs
StatePublished - Jun 2021
Externally publishedYes

Keywords

  • infectious diseases
  • oncology
  • pharmacology

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus'. Together they form a unique fingerprint.

Cite this